Journal of Virology · 2020 · 24 citations · 39 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyImmunotherapy For Skin CancerMelanoma PharmacotherapyOncogenic VirusesOncolytic Virus ImmunotherapyOncolytic Virus TherapyAnti-viral ImmunityGene-armored Oncolytic VirusesHerpes Simplex Virus VectorsOncolytic Viral TherapyOncolytic Viral VectorsOncolytic Virus EngineeringPatient Eligibility CriteriaPatient Enrollment Criteria
T cells for efficacy, our model will enable study of the immunological correlates of protection for VC2 oncolytic virotherapy and oncolytic virotherapy in general. Understanding the mechanisms of efficacious oncolytic virotherapy will inform the rational design of improved oncolytic virotherapies.
39
The Immune Landscape of Cancer
Vésteinn Thórsson, David L. Gibbs, Scott D. Brown et al. · Immunity · 2018 · 6.2K citations · Full text
Medicine, Immunology, Oncology +17
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al. · Nature · 2001 · 2.8K citations
Life Sciences, Immunology, Oncology +12
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov et al. · Cell · 2017 · 1.5K citations · Full text
Medicine, Immunology, Oncology +12
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Robert L. Martuza, Amy Malick, James M. Markert et al. · Science · 1991 · 1K citations
Medicine, Cancer Biology, Oncology +14
Binlei Liu, Max Robinson, Z-Q Han et al. · Gene Therapy · 2003 · 792 citations
Medicine, Cancer Biology, Oncology +10